Interrelationships Between Infliximab and Recombinant Tumor Necrosis Factor- Α in Plasma Using Minimal Physiologically Based Pharmacokinetic Models

Drug Metabolism and Disposition - United States
doi 10.1124/dmd.116.074807
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)


Related search